The weight loss drug market may soon get more crowded. Here are the companies trying to enter the booming space
Publishing timestamp: 2024-01-18 12:14:28
Summary
The article discusses the race among drugmakers to develop weight loss drugs and highlights lesser-known competitors such as Boehringer Ingelheim, Terns Pharmaceuticals, Viking Therapeutics, and Structure Therapeutics. It mentions the dominant players in the market, Novo Nordisk and Eli Lilly, and other large drugmakers hoping to enter the market. The article also discusses the potential growth of the weight loss drug market and the strategies of various companies.
Sentiment: NEUTRAL
Tickers: ROG-CH, VKTX, LLY, TERN, JPM, BAYN-DE, AMGN, PFE, ALT, SAN-FR, UNDEFINED, ZEAL-DK, NOVO.B-DK, AZN-GB,
Keywords: health care industry, biotech and pharmaceuticals, astrazeneca plc, structure therapeutics inc, eli lilly and co, amgen inc, zealand pharma a/s, sanofi sa, pharmaceuticals, altimmune inc, viking therapeutics inc, roche holding ag, bayer ag, breaking news, biotechnology, business, novo nordisk a/s, business news, jpmorgan drn, pfizer inc, terns pharmaceuticals inc,